Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $393.53M.
ENTERPRISE VALUE (EV)
$393.53M
Oculis Holding AG
Market Cap
$495.60M
Enterprise Value (EV)
$393.53M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Oculis Holding AG (OCS) | $495.60M | $393.53M |
| Evolus, Inc. (EOLS)vs › | $490.41M | $610.05M |
| Puma Biotechnology, Inc. (PBYI)vs › | $486.35M | $454.63M |
| Allogene Therapeutics, Inc. (ALLO)vs › | $509.10M | $540.83M |
| 908 Devices Inc. (MASS)vs › | $509.56M | $450.84M |
| Crescent Biopharma, Inc. (CBIO)vs › | $509.80M | $339.64M |
| Arvinas, Inc. (ARVN)vs › | $478.01M | $391.91M |
| Altimmune, Inc. (ALT)vs › | $515.36M | $488.05M |
| Cerus Corporation (CERS)vs › | $475.60M | $534.42M |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.03M | $255.14M |
Market Cap
$495.60M
Total Debt
$633940.54
Cash
$102.70M
Enterprise Value
$393.53M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
